"Logistical issues surrounding obtaining bulk supply of a key ingredient"
Well that bodes real well for being able to ramp up production to a meaningful level.
Not only are they short on manufacturing capability but they can't even source bulk ingredients to even supoort a trial never mind the millions of doses they would like holdersto believethey will be selling.
Laughable!
Ann: MGC PHARMA 2021 CLINICAL TRIALS PROGRAM UPDATE, page-4
Add RGT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
29.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $15.73M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 4408 | 25.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 29.0¢ | 1899 | 2 |
View Market Depth
| Last trade - 16.12pm 08/11/2024 (20 minute delay) ? |
| RGT (ASX) Chart |
Day chart unavailable